Assembly Biosciences (FRA:V7B) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:V7B Assembly Biosciences Inc FRA:V7B
35 GF Score
Price €22.45
! 3 Warning Signs
View Full Analysis

What is Assembly Biosciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Assembly Biosciences  (FRA:V7B) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Assembly Biosciences Cyclically Adjusted PB Ratio Related Terms


Assembly Biosciences Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Assembly Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Assembly Biosciences Cyclically Adjusted PB Ratio Chart

Assembly Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.21 0.13 0.23 0.52

Assembly Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.38 0.53 0.44 0.46

FRA:V7B vs ALLO, TECX, ZVRA: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Assembly Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assembly Biosciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's Cyclically Adjusted PB Ratio falls into.


FRA:V7B
35GF Score
Assembly Biosciences Inc FRA:V7B
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Assembly Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Assembly Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Assembly Biosciences's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=13.468/333.9520*333.9520
=13.468

Current CPI (Jun. 2026) = 333.9520.

Assembly Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201609 55.818 241.428 77.209
201612 52.693 241.432 72.886
201703 43.982 243.801 60.245
201706 34.262 244.955 46.710
201709 27.518 246.819 37.233
201712 56.135 246.524 76.043
201803 49.001 249.554 65.573
201806 44.424 251.989 58.874
201809 93.102 252.439 123.165
201812 86.733 251.233 115.290
201903 79.642 254.202 104.628
201906 71.781 256.143 93.586
201909 66.576 256.759 86.592
201912 89.710 256.974 116.583
202003 84.397 258.115 109.194
202006 86.990 257.797 112.687
202009 84.089 260.280 107.890
202012 69.342 260.474 88.903
202103 62.945 264.877 79.360
202106 53.576 271.696 65.852
202109 49.409 274.310 60.152
202112 37.044 278.802 44.372
202203 32.891 287.504 38.205
202206 29.425 296.311 33.163
202209 25.873 296.808 29.111
202212 19.009 296.797 21.389
202303 14.935 301.836 16.524
202306 11.523 305.109 12.612
202309 8.986 307.789 9.750
202312 6.786 306.746 7.388
202403 5.506 312.332 5.887
202406 5.100 314.175 5.421
202409 3.667 315.301 3.884
202412 4.320 315.605 4.571
202503 3.297 319.799 3.443
202506 2.010 322.561 2.081
202509 9.830 324.800 10.107
202512 11.103 324.054 11.442
202603 10.846 330.213 10.969
202606 13.468 333.952 13.468

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Assembly Biosciences Business Description

Other Exchanges ASMB:USAV7B:Germany
Address Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
35GF Score

Get the complete analysis for FRA:V7B

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.45
Price